Tibet Cheezheng Tibetan Medicine Co., Ltd. (SHE:002287)
23.30
-0.14 (-0.60%)
Apr 17, 2026, 3:04 PM CST
SHE:002287 Market Cap
SHE:002287 has a market cap or net worth of 13.27 billion as of April 17, 2026. Its market cap has increased by 13.15% in one year.
Market Cap
13.27B
Enterprise Value
11.28B
Revenue
2.42B
Ranking
n/a
PE Ratio
19.60
Stock Price
23.30
Market Cap Chart
Since September 3, 2009, SHE:002287's market cap has increased from 7.26B to 13.27B, an increase of 82.67%. That is a compound annual growth rate of 3.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2026 | 13.27B | -1.52% |
| Dec 31, 2025 | 13.47B | 18.75% |
| Dec 31, 2024 | 11.35B | -4.85% |
| Dec 29, 2023 | 11.92B | -1.14% |
| Dec 30, 2022 | 12.06B | -25.24% |
| Dec 31, 2021 | 16.13B | 17.84% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Staidson (Beijing) BioPharmaceuticals | 15.05B |
| Inner Mongolia Furui Medical Science | 14.71B |
| Vcanbio Cell & Gene Engineering Corp., | 13.06B |
| Chengzhi | 12.86B |
| Pacific Shuanglin Bio-pharmacy | 12.41B |
| InventisBio | 12.30B |
| Hualan Biological Vaccine | 11.97B |
| Chongqing Genrix Biopharmaceutical | 11.84B |